NIAID Launches Universal Flu Vaccine Study
A major research priority for NIAID is finding a universal flu vaccine--one that could durably protect all age groups against multiple influenza strains. NIAID has launched a new study testing a potential vaccine candidate.
Early-Stage Ebola Treatment Trial Begins
NIAID scientists are evaluating a monoclonal antibody treatment for Ebola in a Phase 1 clinical trial at the NIH Clinical Center.
Asthma Awareness Month
Read NIH's statement on World Asthma Day 2018 and watch a video featuring clinical research volunteers.